학술논문

Intratumoral administration of a TLR9-adjuvanted nanoparticle cancer vaccine stimulates more effective immunity in both injected and un-injected tumor sites compared to subcutaneous administration
Document Type
Journal
Source
CANCER RESEARCH; JUL 2017, 77 2p. Supplement: 13
Subject
Language
English
ISSN
15387445